Selection of the treatment strategies of myelodysplastic syndromes based on clone category / 白血病·淋巴瘤
Journal of Leukemia & Lymphoma
;
(12): 759-762, 2011.
Artículo
en Chino
| WPRIM
| ID: wpr-472395
ABSTRACT
Myelodysplastic syndromes(MDS) are heterogeneous clonal stem cell disorders.There are about 40 %-60 % MDS patients with abnormal karyotype.To analyze the clone category is not only useful for diagnosis and evaluating prognosis,but also helpful for the selection of optimal therapy strategies to improve the treatment efficacy.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Journal of Leukemia & Lymphoma
Año:
2011
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS